Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study

Headache

Volumn 42, Issue 1, 2002, Pages 49-55

  Winner, Paul ^a   Lewis, Donald ^b   Visser, W Hester ^c   Jiang, Kaihong ^c   Ahrens, Suzanne ^c   Evans, Judith K ^c  

^a Palm Beach Headache Center   (United States)

^b Children's Hospital of the King's Daughters   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adolescents; Migraine; Pediatric; Rizatriptan

Indexed keywords

PLACEBO; RIZATRIPTAN;

ADOLESCENT; ANALGESIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SOMNOLENCE; VERTIGO; XEROSTOMIA;

ADOLESCENT; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PLACEBOS; SEROTONIN AGONISTS; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES; TRYPTAMINES;

EID: 0036168812     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02013.x     Document Type: Article

References (15)

1. Prevalence of headache and migraine in schoolchildren
2. An epidemiologic study of headache among adolescents and young adults
3. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents
4. Effect of age on the fulfilment of the IHS criteria for migraine in children at a headache clinic
5. Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study
6. Intranasal sumatriptan for the acute treatment of migraine
7. Efficacy, safety and tolerability of oral eletriptan (40 mg) for the treatment of acute migraine in adolescents (12-17 years)
8. Sumatriptan for migraine attacks in children: A randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently than adults?
9. A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults
10. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study
11. Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
12. Pharmacokinetics of rizatriptan in adolescent migraineurs
13. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
14. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks
15. Rizatriptan 5 mg versus sumatriptan 50 mg in the acute treatment of migraine